[1] MONTEIRO J, LESLIE M, MOGHADASIAN M H, et al.The role of n-6 and n-3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and non-alcoholic fatty liver disease[J].Food & Function, 2014, 5(3):426-435.
[2] PATTERSON E, WALL R, FITZGERALD G F, et al.Health implications of high dietary omega-6 polyunsaturated fatty acids[J].Journal of Nutrition and Metabolism, 2012, 2012:539426.
[3] POUDYAL H, PANCHAL S K, DIWAN V, et al.Omega-3 fatty acids and metabolic syndrome:effects and emerging mechanisms of action[J].Progress in Lipid Research, 2011, 50(4):372-387.
[4] BATAILLE A M, MANAUTOU J E.Nrf2:a potential target for new therapeutics in liver disease[J].Clinical Pharmacology & Therapeutics, 2012, 92(3):340-348.
[5] WAKABAYASHI N, SLOCUM S L, SKOKO J J, et al.When NRF2 talks, who's listening?[J].Antioxidants & Redox Signaling, 2010, 13(11):1649-1663.
[6] LIANG F Q, ALSSADI R, MOREHEAD P, et al.Enhanced expression of glutathione-S-transferase A1-1 protects against oxidative stress in human retinal pigment epithelial cells[J].Experimental Eye Research, 2005, 80(1):113-119.
[7] SYKIOTIS G P, HABEOS I G, SAMUELSON A V, et al.The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation[J].Current Opinion in Clinical Nutrition and Metabolic Care, 2011, 14(1):41-48.
[8] QI X L, WU S G, ZHANG H J, et al.Effects of dietary conjugated linoleic acids on lipid metabolism and antioxidant capacity in laying hens[J].Archives of Animal Nutrition, 2011, 65(5):354-365.
[9] MOLLICA M P, TRINCHESE G, CAVALIERE G, et al.c9, t11-conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway[J].Journal of Lipid Research, 2014, 55(5):837-849.
[10] SIMOPOULOS A P.The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases[J].Experimental Biology and Medicine, 2008, 233(6):674-688.
[11] MIRMIRAN P, HOSSEINPOUR-NIAZI S, NADERI Z, et al.Association between interaction and ratio of ω-3 and ω-6 polyunsaturated fatty acid and the metabolic syndrome in adults[J].Nutrition, 2012, 28(9):856-863.
[12] BEYAZIT Y, PURNAK T, KEKILLI M.Omega-3 fatty acids:a promising alternative treatment approach for patients with nonalcoholic fatty liver disease[J].Digestive Diseases and Sciences, 2010, 55(8):2422-2423.
[13] KOHJIMA M, ENJOJI M, HIGUCHI N, et al.The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells[J].
In Vitro Cellular & Developmental Biology-Animal, 2009, 45(1/2):6-9.
[14] HUERTA-OLVERA S G, MACÍAS-BARRAGÁN J, RAMOS-MÁRQUEZ M E, et al.Alpha-lipoic acid regulates heme oxygenase gene expression and nuclear Nrf2 activation as a mechanism of protection against arsenic exposure in HepG2 cells[J].Environmental Toxicology and Pharmacology, 2010, 29(2):144-149.
[15] DELPLANQUE B, DU Q, AGNANI G, et al.A dairy fat matrix providing alpha-linolenic acid (ALA) is better than a vegetable fat mixture to increase brain DHA accretion in young rats[J].Prostaglandins, Leukotrienes and Essential Fatty Acids, 2013, 88(1):115-120.
京公网安备 11010802041926号